Advertisement
Screener

CAMP4 Therapeutics Corporation (CAMP) Market Cap

Camp4 Therapeutics Corp Market Cap

Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.

  • Camp4 Therapeutics Corp market cap for the quarter ending 2026-08-12 was $284.27M, a 705.72% increase year-over-year.
  • Camp4 Therapeutics Corp market cap for the quarter ending 2026-06-30 was $227.7M, a 665.70% increase year-over-year.
  • Camp4 Therapeutics Corp market cap for the quarter ending 2026-05-06 was $212.38M, a 354.05% increase year-over-year.
  • Camp4 Therapeutics Corp market cap for the quarter ending 2026-03-31 was $231.07M, a 186.59% increase year-over-year.
  • Camp4 Therapeutics Corp market cap for fiscal 2026 was $284.27M.
  • Camp4 Therapeutics Corp market cap for fiscal 2025 was $317.38M, a 201.82% increase from fiscal 2024.
  • Camp4 Therapeutics Corp market cap for fiscal 2024 was $105.16M.
Available history
2024-11-18 to 2026-08-12
Data captured

Historical Market Cap

DateMarket Cap
2026-08-12$284.27M
2026-06-30$227.7M
2026-05-06$212.38M
2026-03-31$231.07M
2026-03-04$207.68M
2025-12-31$317.38M
2025-11-03$185.18M
2025-09-30$141.58M
2025-08-05$35.28M
2025-06-30$29.74M
2025-05-06$46.77M
2025-03-31$80.63M
2025-03-13$110.08M
2024-12-31$105.16M
2024-11-18$137.5M

Annual Market Cap

DateMarket Cap
2026-08-12$284.27M
2025-12-31$317.38M
2024-12-31$105.16M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51